- REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century
[作者：Claassen, DO; Josephs, KA; Ahlskog, JE; Silber, MH; Tippmann-Peikert, M; Boeve, BF,期刊：Neurology, 页码：494-499 , 文章类型： Article，,卷期：2010年75-6]
- Background: Idiopathic REM sleep behavior disorder (RBD) may be the initial manifestation of synucleinopathies (Parkinson disease [PD], multiple system atrophy [MSA], or dementia with Lewy bodies [DLB]).Methods: We used ...
- Mild cognitive impairment in prediagnosed Huntington disease
[作者：Duff, K; Paulsen, J; Mills, J; Beglinger, LJ; Moser, DJ; Smith, MM; Langbehn, D; Stout, J; Queller, S; Harrington, DL,期刊：Neurology, 页码：500-507 , 文章类型： Article，,卷期：2010年75-6]
- Background: Cognitive decline has been reported in Huntington disease (HD), as well as in the period before diagnosis of motor symptoms (i.e., pre-HD). However, the severity, frequency, and characterization of cognitive ...
- Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus
[作者：Tan, EK; Kwok, HK; Tan, LC; Zhao, WT; Prakash, KM; Au, WL; Pavanni, R; Ng, YY; Satake, W; Zhao, Y; Toda, T; Liu, JJ,期刊：Neurology, 页码：508-512 , 文章类型： Article，,卷期：2010年75-6]
- Objective: A genome-wide association study (GWAS) in the Japanese population identified 2 new Parkinson disease (PD) susceptibility loci on 1q32 (PARK16) (OMIM 613164) and BST1. We analyzed single nucleotide polymorphism...
- Zonisamide discontinuation due to psychiatric and cognitive adverse events A case-control study
[作者：White, JR; Walczak, TS; Marino, SE; Beniak, TE; Leppik, IE; Birnbaum, AK,期刊：Neurology, 页码：513-518 , 文章类型： Article，,卷期：2010年75-6]
- Objectives: Zonisamide (ZNS) is an antiepileptic drug (AED) that has been associated with psychiatric adverse events (PAE) and cognitive adverse events (CAE); controlled studies evaluating these adverse events are limite...
- Adjunctive brivaracetam for refractory partial-onset seizures A randomized, controlled trial
[作者：French, JA; Costantini, C; Brodsky, A; von Rosenstiel, P,期刊：Neurology, 页码：519-525 , 文章类型： Article，,卷期：2010年75-6]
- Objective: To explore efficacy and safety/tolerability of adjunctive brivaracetam (BRV), a novel, high-affinity synaptic vesicle protein 2A ligand, which also inhibits neuronal voltage-dependent sodium channels, in patie...
- Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser
[作者：Yang, NCC; Lee, MJ; Chao, CC; Chuang, YT; Lin, WM; Chang, MF; Hsieh, PC; Kan, HW; Lin, YH; Yang, CC; Chiu, MJ; Liou, HH; Hsieh, ST,期刊：Neurology, 页码：532-538 , 文章类型： Article，,卷期：2010年75-6]
- Objective: Familial amyloid polyneuropathy (FAP) due to amyloidogenic transthyretin (TTR) is often associated with impairment of thermonociceptive functions. This study investigated skin innervation and its clinical sign...
- Dominant spinal muscular atrophy with lower extremity predominance Linkage to 14q32
[作者：Harms, MB; Allred, P; Gardner, R; Filho, JAF; Florence, J; Pestronk, A; Al-Lozi, M; Baloh, RH,期刊：Neurology, 页码：539-546 , 文章类型： Article，,卷期：2010年75-6]
- Objective: Spinal muscular atrophies (SMAs) are hereditary disorders characterized by weakness from degeneration of spinal motor neurons. Although most SMA cases with proximal weakness are recessively inherited, rare fam...
- Dominant-negative effects of a novel mutation in the filamin myopathy
[作者：Kono, S; Nishio, T; Takahashi, Y; Goto-Inoue, N; Kinoshita, M; Zaima, N; Suzuki, H; Fukutoku-Otsuji, A; Setou, M; Miyajima, H,期刊：Neurology, 页码：547-554 , 文章类型： Article，,卷期：2010年75-6]
- Background: Filamin myopathy is associated with mutations in the filamin C gene ( FLNC) and is a myofibrillar myopathy characterized by focal myofibrillar destruction and cytoplasmic aggregates containing several Z-disk-...
- Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA SAMURAI rt-PA Registry
[作者：Nezu, T; Koga, M; Kimura, K; Shiokawa, Y; Nakagawara, J; Furui, E; Yamagami, H; Okada, Y; Hasegawa, Y; Kario, K; Okuda, S; Nishiyama, K; Naganuma, M; Minematsu, K; Toyoda, K,期刊：Neurology, 页码：555-561 , 文章类型： Article，,卷期：2010年75-6]
- Objective: To evaluate whether the pretreatment Alberta Stroke Programme Early CT Score (ASPECTS) assessed using diffusion-weighted imaging (DWI) predicts stroke outcomes at 3 months following IV recombinant tissue-type ...
|